Bio Tuesday's  Instablog

Bio Tuesday
Send Message
Stephen is the President of Kilmer Lucas Inc. ( and BioTuesday Publishing Corporation ( Prior to founding both firms, he was the VP of Investor & Public Affairs for OccuLogix Inc., a Boston-based medical device company. Before managing OccuLogix’ spin-out... More
My company:
BioTuesday Publishing Corporation, a wholly-owned subsidiary of Kilmer Lucas Inc.
My blog:
  • Canaccord ups AEterna price target 0 comments
    May 14, 2010 2:08 PM | about stocks: AEZS

    May 14, 2010 by leonardzehr · Leave a Comment 

    Canaccord Genuity has raised its price target on “speculative buy-rated” AEterna Zentaris (AEZS 1.86 ↓6.06%)(NASDAQ:AEZS; TSX:AEZ (1.92 ↓2.04%)) to $2.60 (U.S.) from $1.65 after updating its valuation to include the colorectal cancer indication for the company’s perifosine drug.

    In a new report, analyst Neil Maruoka says he figures perifosine will have peak revenues of $400 million treating colorectal cancer and gives the drug a 55% probability of clinical success.  That’s the same probability that he projects for perifosine’s multiple myeloma indication.

    The drug has advanced into Phase 3 studies in multiple myeloma and colorectal cancer, and “we believe that results from these studies will be major drivers for the stock,” he added. 

    Disclosure: No positions
    Stocks: AEZS
Back To Bio Tuesday's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.